#BestOf2021 #FirstWomen #newreleases #shwetakatti #griefOrlove
#News

Is Pfizer Available In India? Here’s What You Need To Know About The Vaccine

Precautionary Dose Of Covid 19 Vaccine, Precautionary Dose Of Covid Vaccine, vaccine certificate compulsory, covid-19 vaccination of children ,Children COVID Vaccine Registration ,third vaccine dose, Covaxin For Kids, COVID in fully vaccinated peopleThird COVID-19 Vaccine Dose, Johnson & Johnson’s Vaccine, Covid vaccine trial on children, viral shedding, comirnaty, Sanofi-GSK COVID-19 vaccine, COVID vaccine her immunity, Delta Plus Variant Escape Vaccines, Johnson and Johnson vaccine ,Johnson and Johnson vaccine ,Trials Of Covavax On Children, Janssen Vaccine, janssen-vaccine, Heart Inflammation Risk Warning, pfizer vaccine india ,Best COVID Vaccine, mRNA COVID-19 vaccine, Pfizer vaccine for children, Punjab Students Planning To Go Abroad ,vaccine free ,COVID-19 vaccine after effect Pfizer and BioNTech Vaccine For Children, COVID vaccine start working, Covaxin trials on children ,Two COVID-19 Vaccine Doses Same Day, Pfizer-BioNTech Vaccine For Adolescents, slot for COVID-19 vaccination ,Moderna Pfizer Turns Down States Vaccine,India-Pfizer ,vaccine for children ,Sputnik Light ,Delayed Second Pfizer COVID-19 Shot, Pfizer Vaccine, rare COVID vaccine side-effects, Biological E. Vaccine Candidate, valneva vaccine, woman hates needles , Pfizer Donates DrugsVaccination for pregnant women ,COVAXIN ,COVID-19 reinfection ,co-win ,vaccine registration ,COVID-19 Vaccine For Below 18 Years, Free COVID-19 Vaccination ,Covishield Vaccine Open Market Price, Free COVID-19 vaccine ,COVID19 Vaccination Phase 3 ,18 years above eligible ,Priority Vaccines For Journalists ,Sputnik V Vaccine ,anti-rabies vaccine ,double shots of covid-19 vaccine ,100-Year-Old Woman vaccinated ,Bollywood stars COVID-19 vaccine ,Germany suspends AstraZeneca, After effects of COVID-19 infection ,Oxford Vaccine Europe Ban, Johnson Vaccine, cowin app children registration, What Is Corbevax
Pfizer vaccine India: Pfizer CEO Albert Bourla stated the status of approval of the vaccine from the Indian Government on June 22 and also mentioned that post-approval, one billion doses will be sent to India within this year.

As the Pfizer vaccine is in its final stage for its approval in India, here are some facts about the much-awaited process:

When will Pfizer be available in India?

The US-based company is in the final stages of getting approval for its Covid-19 vaccine from the Indian government, and when approved, the pharma giant will supply one billion doses to India within this year, according to a report.

How Much Pfizer Vaccine Will Be Available In India?

The US-based pharma giant’s CEO Albert Bourla informed at the USA-India Chamber of Commerce annual summit that India will receive 2 billion doses, of which, 1 billion will be provided within this year itself. “We have pledged to provide one billion doses of Covid-19 vaccine this year” he added, “to nations under the mid and low-income category, including India.”

Will The Pfizer Vaccine Be Approved In India?

Bourla confirmed at the summit that they are in a good place to get the vaccine approved in India. “While the Serum Institute will continue to be the backbone of India’s vaccine plan, we hope to also contribute, Pfizer and Moderna vaccines will provide additional doses to India’s vaccination drive”

What Are The Governments’ Plans On Approving Pfizer?

Earlier, it was reported that the Centre may grant indemnity to the vaccine makers so that the process of approval of the vaccines can be hastened. The given indemnity will ensure makers from legal proceedings, which assures that they can’t be sued in India.

The American multinational pharmaceutical and biotechnology corporation had previously donated some critical life-saving medicines to India at the time of the deadly second wave of Covid-19. As stated by Boula, Pfizer is committed to being a partner in India’s fight against this disease and is quickly working to mobilise the largest humanitarian relief effort in the company’s history.

Point To Hai